...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
Reply New Message
Back To Forum List View
Zenith Epigentics and Resverlogix update 22 Jan 2018
2
tada
Jan 31, 2018 04:03PM
Icon president Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
3
SanFrancisco99
Jan 31, 2018 10:46PM
Icon president Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
4
BearDownAZ
Feb 01, 2018 11:38AM
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
5
tada
Feb 01, 2018 12:04PM

Not to get too ahead of ourselves but I really wonder if it is possible  for a bidding war between 2 BP's  for Zenith Ep.   It has been said that it is alot easier to buyout a private company than a public co based on the scrutiny of the evaluation of the public co,

 

Its alot easier to justify paying a few billion $ in a CVR deal with Zenith overtime on miliestone payments than to say buyout RVX that has a marketcap of $350 CAD and ask for say $5 billion or more, then again a CVR deal could be done with RVX as well.... just a thought 

6 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply